Characteristic Fetal Brain MRI Abnormalities in Pyruvate Dehydrogenase Complex Deficiency

Olivier Fortin1, Kelsey Christoffel1,2, Abdullah Shoaib3,4

  • 1Zickler Family Prenatal Pediatrics Institute, Children's National Hospital, Washington, District of Columbia, USA, 20010.

Insights

Pyruvate dehydrogenase complex deficiency (PDCD) shows specific prenatal brain MRI findings. Early second-trimester cystic changes in ganglionic eminences may be a novel diagnostic marker for this metabolic disorder.

Area of Science:

  • Neuroimaging
  • Genetics
  • Mitochondrial Metabolism

Background:

  • Pyruvate dehydrogenase complex deficiency (PDCD) is a genetic mitochondrial metabolism disorder.
  • Neonatal brain imaging in PDCD is documented, but prenatal MRI findings are less understood.
  • This study aims to describe prenatal neurological and systemic manifestations of PDCD using fetal imaging and genomic data.

Approach:

  • Retrospective review of medical records, fetal MRI data, and genetic testing results.
  • Inclusion of all fetuses diagnosed with genetic PDCD who underwent fetal MRI.
  • Descriptive reporting of imaging and clinical findings.

Key Points:

  • Most PDCD fetuses exhibited corpus callosum dysgenesis, abnormal gyration, reduced brain volumes, and periventricular cystic lesions.
  • Second-trimester fetuses showed enlarged ganglionic eminences with cystic changes; third-trimester fetuses had germinolytic cysts.
  • One case presented with intraventricular hemorrhages, and another with midbrain malformation and hydrocephalus.

Conclusions:

  • Fetal MRI findings in PDCD resemble neonatal findings but can be subtle early in gestation.
  • Cystic changes in ganglionic eminences during the second trimester may serve as a novel early diagnostic marker for PDCD.
  • Prenatal MRI identification of PDCD hallmarks can guide genetic counseling, pregnancy decisions, and neonatal care.